mebifon

Ukraine

Drugs containing this active substance

  • MEBYPHON®

    The drug is used to treat malignant tumors of the breast, prostate, and lungs that have metastasized to the bones. It is also prescribed for melanoma, lymphoproliferative diseases with bone involvement, and hypercalcemia (elevated calcium levels) caused by cancer.

    Form: solution for injection

    Active substance Dosage
    mebifon 15 mg/ml

    ATC: L01XX M05BA

    Manufacturer: Farmak JSC